Cargando…
Psychometric testing of the Functional Assessment of Cancer Therapy/Gynecologic Oncology Group—Neurotoxicity (FACT/GOG-Ntx) subscale in a longitudinal study of cancer patients treated with chemotherapy
BACKGROUND: The aim of this study was to evaluate the psychometric properties of the Functional Assessment of Cancer Therapy/Gynecologic Oncology Group—Neurotoxicity (FACT/GOG-Ntx) subscale in a longitudinal study of cancer patients treated with chemotherapy. METHODS: Patients were assessed with the...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7376939/ https://www.ncbi.nlm.nih.gov/pubmed/32703223 http://dx.doi.org/10.1186/s12955-020-01493-y |
_version_ | 1783562128845701120 |
---|---|
author | Cheng, Hui Lin Lopez, Violeta Lam, Simon Ching Leung, Anthony Kwun To Li, Yu Chung Wong, Kam Hung Au, Joseph Siu Kie Sundar, Raghav Chan, Alexandre De Ng, Terrence Rong Suen, Lorna Kwai Ping Chan, Choi Wan Yorke, Janelle Molassiotis, Alex |
author_facet | Cheng, Hui Lin Lopez, Violeta Lam, Simon Ching Leung, Anthony Kwun To Li, Yu Chung Wong, Kam Hung Au, Joseph Siu Kie Sundar, Raghav Chan, Alexandre De Ng, Terrence Rong Suen, Lorna Kwai Ping Chan, Choi Wan Yorke, Janelle Molassiotis, Alex |
author_sort | Cheng, Hui Lin |
collection | PubMed |
description | BACKGROUND: The aim of this study was to evaluate the psychometric properties of the Functional Assessment of Cancer Therapy/Gynecologic Oncology Group—Neurotoxicity (FACT/GOG-Ntx) subscale in a longitudinal study of cancer patients treated with chemotherapy. METHODS: Patients were assessed with the FACT/GOG-Ntx subscale, European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Chemotherapy-Induced Peripheral Neuropathy Scale 20 (EORTC QLQ-CIPN20), National Cancer Institute -Common Terminology Criteria for Adverse Events (NCI-CTCAE), and light touch test using 10 g monofilament for up to ten assessment points from baseline (prior to initiation of first chemotherapy), after the end of each cycle (up to 6 cycles, 3 weeks per cycle), and at 6, 9, and 12 months after starting chemotherapy. Psychometric analyses included internal consistency reliability, convergent validity, factorial validity, sensitivity to change and responsiveness (minimal clinically important difference, MCID). RESULTS: Cronbach’s alpha coefficients of the FACT/GOG-Ntx subscale were 0.82–0.89 across assessment points. The subscale strongly correlated with the EORTC QLQ-CIPN20 (r = 0.79–0.93) but low-to-moderately correlated with the NCI-CTCAE sensory (r(s) = 0.23–0.45) and motor items (r(s) = 0.15–0.50) as well as the monofilament test (r(s) = 0.23–0.47). The hypothesized 4-factor structure of the FACT/GOG-Ntx subscale was not confirmed at assessment points (χ2/df = 2.26–8.50; all P < 0.001). The subscale exhibited small-to-moderate sensitivity to change (r = 0.17–0.37). The MCIDs were between 1.38 and 3.68. CONCLUSION: The FACT/GOG-Ntx subscale has satisfactory reliability, validity, sensitivity to change and responsiveness to evaluate CIPN in cancer patients. Future research is needed to explore the factorial structure of the FACT/GOG-Ntx subscale as the published four-factor structure was not supported in this study. |
format | Online Article Text |
id | pubmed-7376939 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-73769392020-08-04 Psychometric testing of the Functional Assessment of Cancer Therapy/Gynecologic Oncology Group—Neurotoxicity (FACT/GOG-Ntx) subscale in a longitudinal study of cancer patients treated with chemotherapy Cheng, Hui Lin Lopez, Violeta Lam, Simon Ching Leung, Anthony Kwun To Li, Yu Chung Wong, Kam Hung Au, Joseph Siu Kie Sundar, Raghav Chan, Alexandre De Ng, Terrence Rong Suen, Lorna Kwai Ping Chan, Choi Wan Yorke, Janelle Molassiotis, Alex Health Qual Life Outcomes Research BACKGROUND: The aim of this study was to evaluate the psychometric properties of the Functional Assessment of Cancer Therapy/Gynecologic Oncology Group—Neurotoxicity (FACT/GOG-Ntx) subscale in a longitudinal study of cancer patients treated with chemotherapy. METHODS: Patients were assessed with the FACT/GOG-Ntx subscale, European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Chemotherapy-Induced Peripheral Neuropathy Scale 20 (EORTC QLQ-CIPN20), National Cancer Institute -Common Terminology Criteria for Adverse Events (NCI-CTCAE), and light touch test using 10 g monofilament for up to ten assessment points from baseline (prior to initiation of first chemotherapy), after the end of each cycle (up to 6 cycles, 3 weeks per cycle), and at 6, 9, and 12 months after starting chemotherapy. Psychometric analyses included internal consistency reliability, convergent validity, factorial validity, sensitivity to change and responsiveness (minimal clinically important difference, MCID). RESULTS: Cronbach’s alpha coefficients of the FACT/GOG-Ntx subscale were 0.82–0.89 across assessment points. The subscale strongly correlated with the EORTC QLQ-CIPN20 (r = 0.79–0.93) but low-to-moderately correlated with the NCI-CTCAE sensory (r(s) = 0.23–0.45) and motor items (r(s) = 0.15–0.50) as well as the monofilament test (r(s) = 0.23–0.47). The hypothesized 4-factor structure of the FACT/GOG-Ntx subscale was not confirmed at assessment points (χ2/df = 2.26–8.50; all P < 0.001). The subscale exhibited small-to-moderate sensitivity to change (r = 0.17–0.37). The MCIDs were between 1.38 and 3.68. CONCLUSION: The FACT/GOG-Ntx subscale has satisfactory reliability, validity, sensitivity to change and responsiveness to evaluate CIPN in cancer patients. Future research is needed to explore the factorial structure of the FACT/GOG-Ntx subscale as the published four-factor structure was not supported in this study. BioMed Central 2020-07-23 /pmc/articles/PMC7376939/ /pubmed/32703223 http://dx.doi.org/10.1186/s12955-020-01493-y Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Cheng, Hui Lin Lopez, Violeta Lam, Simon Ching Leung, Anthony Kwun To Li, Yu Chung Wong, Kam Hung Au, Joseph Siu Kie Sundar, Raghav Chan, Alexandre De Ng, Terrence Rong Suen, Lorna Kwai Ping Chan, Choi Wan Yorke, Janelle Molassiotis, Alex Psychometric testing of the Functional Assessment of Cancer Therapy/Gynecologic Oncology Group—Neurotoxicity (FACT/GOG-Ntx) subscale in a longitudinal study of cancer patients treated with chemotherapy |
title | Psychometric testing of the Functional Assessment of Cancer Therapy/Gynecologic Oncology Group—Neurotoxicity (FACT/GOG-Ntx) subscale in a longitudinal study of cancer patients treated with chemotherapy |
title_full | Psychometric testing of the Functional Assessment of Cancer Therapy/Gynecologic Oncology Group—Neurotoxicity (FACT/GOG-Ntx) subscale in a longitudinal study of cancer patients treated with chemotherapy |
title_fullStr | Psychometric testing of the Functional Assessment of Cancer Therapy/Gynecologic Oncology Group—Neurotoxicity (FACT/GOG-Ntx) subscale in a longitudinal study of cancer patients treated with chemotherapy |
title_full_unstemmed | Psychometric testing of the Functional Assessment of Cancer Therapy/Gynecologic Oncology Group—Neurotoxicity (FACT/GOG-Ntx) subscale in a longitudinal study of cancer patients treated with chemotherapy |
title_short | Psychometric testing of the Functional Assessment of Cancer Therapy/Gynecologic Oncology Group—Neurotoxicity (FACT/GOG-Ntx) subscale in a longitudinal study of cancer patients treated with chemotherapy |
title_sort | psychometric testing of the functional assessment of cancer therapy/gynecologic oncology group—neurotoxicity (fact/gog-ntx) subscale in a longitudinal study of cancer patients treated with chemotherapy |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7376939/ https://www.ncbi.nlm.nih.gov/pubmed/32703223 http://dx.doi.org/10.1186/s12955-020-01493-y |
work_keys_str_mv | AT chenghuilin psychometrictestingofthefunctionalassessmentofcancertherapygynecologiconcologygroupneurotoxicityfactgogntxsubscaleinalongitudinalstudyofcancerpatientstreatedwithchemotherapy AT lopezvioleta psychometrictestingofthefunctionalassessmentofcancertherapygynecologiconcologygroupneurotoxicityfactgogntxsubscaleinalongitudinalstudyofcancerpatientstreatedwithchemotherapy AT lamsimonching psychometrictestingofthefunctionalassessmentofcancertherapygynecologiconcologygroupneurotoxicityfactgogntxsubscaleinalongitudinalstudyofcancerpatientstreatedwithchemotherapy AT leunganthonykwunto psychometrictestingofthefunctionalassessmentofcancertherapygynecologiconcologygroupneurotoxicityfactgogntxsubscaleinalongitudinalstudyofcancerpatientstreatedwithchemotherapy AT liyuchung psychometrictestingofthefunctionalassessmentofcancertherapygynecologiconcologygroupneurotoxicityfactgogntxsubscaleinalongitudinalstudyofcancerpatientstreatedwithchemotherapy AT wongkamhung psychometrictestingofthefunctionalassessmentofcancertherapygynecologiconcologygroupneurotoxicityfactgogntxsubscaleinalongitudinalstudyofcancerpatientstreatedwithchemotherapy AT aujosephsiukie psychometrictestingofthefunctionalassessmentofcancertherapygynecologiconcologygroupneurotoxicityfactgogntxsubscaleinalongitudinalstudyofcancerpatientstreatedwithchemotherapy AT sundarraghav psychometrictestingofthefunctionalassessmentofcancertherapygynecologiconcologygroupneurotoxicityfactgogntxsubscaleinalongitudinalstudyofcancerpatientstreatedwithchemotherapy AT chanalexandre psychometrictestingofthefunctionalassessmentofcancertherapygynecologiconcologygroupneurotoxicityfactgogntxsubscaleinalongitudinalstudyofcancerpatientstreatedwithchemotherapy AT dengterrencerong psychometrictestingofthefunctionalassessmentofcancertherapygynecologiconcologygroupneurotoxicityfactgogntxsubscaleinalongitudinalstudyofcancerpatientstreatedwithchemotherapy AT suenlornakwaiping psychometrictestingofthefunctionalassessmentofcancertherapygynecologiconcologygroupneurotoxicityfactgogntxsubscaleinalongitudinalstudyofcancerpatientstreatedwithchemotherapy AT chanchoiwan psychometrictestingofthefunctionalassessmentofcancertherapygynecologiconcologygroupneurotoxicityfactgogntxsubscaleinalongitudinalstudyofcancerpatientstreatedwithchemotherapy AT yorkejanelle psychometrictestingofthefunctionalassessmentofcancertherapygynecologiconcologygroupneurotoxicityfactgogntxsubscaleinalongitudinalstudyofcancerpatientstreatedwithchemotherapy AT molassiotisalex psychometrictestingofthefunctionalassessmentofcancertherapygynecologiconcologygroupneurotoxicityfactgogntxsubscaleinalongitudinalstudyofcancerpatientstreatedwithchemotherapy |